Glenhill Advisors’s Allergan plc AGN Stock Holding History

Glenhill Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-120,861	Closed	-$36.7M	–	55
2015 Q2	$36.7M	Buy	+120,861	New	+$36M	2.59%	19

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Glenhill Advisors's AGN Position: Q3 2015 in Review

Glenhill Advisors sold out of Allergan plc (AGN) in Q3 2015, closing a stake of 120,861 shares — an estimated $36.7M sold.

Glenhill Advisors first reported a position in AGN in Q2 2015 and held it in 1 quarter. The position peaked at $36.7M in Q2 2015. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

Glenhill Advisors reported no remaining Allergan plc position as of Q3 2015 after selling out during the quarter.
Glenhill Advisors sold 120,861 Allergan plc shares in Q3 2015, an estimated $36.7M.
Glenhill Advisors first reported a position in Allergan plc in Q2 2015 and held it in 1 quarter.
Glenhill Advisors's Allergan plc position peaked at $36.7M in Q2 2015.
1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Glenhill Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.